Clinical observation of efficacy and safety of pemetrexed plus platinum as the first–line chemotherapy with advanced non-squamous non-small cell lung cancer
Background and purpose: The effective rate of first-line chemotherapy for advanced lung cancer is 30%-40%. The purpose of this study was to evaluate the efficacy and adverse effects of pemetrexed combined with carboplatin or cisplatin in the treatment of patients with advanced non-squamous non-small...
Zapisane w:
| Główni autorzy: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Editorial Office of China Oncology
2014-11-01
|
| Seria: | Zhongguo aizheng zazhi |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.china-oncology.com/thesisDetails#10.3969/j.issn.1007-3969.2014.08.009 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
